The market performance of AC Immune SA’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $5.14 on 12/28/23, while the lowest value for the same duration was $2.25 on 04/26/24.
52-week price history of ACIU Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. AC Immune SA’s current trading price is -30.93% away from its 52-week high, while its distance from the 52-week low is 57.78%. The stock’s price range during the 52-week period has remained between $2.25 and $5.14. In the Healthcare sector, the company’s shares saw a trading volume of around 0.76 million for the day, which was evidently higher than the average daily volume of 93160.0 over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
AC Immune SA (ACIU) has experienced a quarterly rise of 5.34% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 353.87M and boasts a workforce of 161 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.41, with a change in price of -0.46. Similarly, AC Immune SA recorded 136,323 in trading volume during the last 100 days, posting a change of -11.47%.
Examining ACIU’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ACIU stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
ACIU Stock Stochastic Average
AC Immune SA’s raw stochastic average for the past 50 days is presently 63.56%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 69.44%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 57.96% and 58.12%, respectively.
ACIU Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -29.00%.However, over the last six months, we can see a weaker performance of 4.11%. Over the last 30 days, the price of ACIU has fallen by 11.29%. And in the last five days, it has surged by 8.56%.
